Katalog der Deutschen Nationalbibliothek

Neuigkeiten Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
 
 
 


Ergebnis der Suche nach: "000000000"
im Bestand: Gesamter Bestand

201 - 210 von 647
<< < > >>


Artikel 201 Economic Burden of Epilepsy among the Privately Insured in the US
Enthalten in PharmacoEconomics Bd. 28, 29.9.2012, Nr. 8, date:8.2010: 675-685
Online Ressource
Artikel 202 Economic Burden of Multiple Sclerosis
Enthalten in PharmacoEconomics Bd. 28, 23.9.2012, Nr. 5, date:5.2010: 363-379
Online Ressource
Artikel 203 Economic efficiency of alcohol policy
Enthalten in Applied health economics and health policy Bd. 8, 6.8.2012, Nr. 5, date:9.2010: 351-354
Online Ressource
Artikel 204 Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy
Enthalten in PharmacoEconomics Bd. 28, 18.10.2012, Nr. 11, date:11.2010: 1041-1054
Online Ressource
Artikel 205 Economic Evaluation of Smoking-Cessation Therapies
Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 7, date:7.2012: 551-564
Online Ressource
Artikel 206 Economic evaluations of adult weight management interventions
Enthalten in Applied health economics and health policy Bd. 10, 6.8.2012, Nr. 3, date:5.2012: 145-162
Online Ressource
Artikel 207 Economic Evaluations of Childhood Influenza Vaccination
Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 8, date:8.2012: 647-660
Online Ressource
Artikel 208 Effect of Memantine on Resting State Default Mode Network Activity in Alzheimer’s Disease
Enthalten in Drugs & aging Bd. 28, 17.10.2012, Nr. 3, date:3.2011: 205-217
Online Ressource
Artikel 209 Effect of Oseltamivir on Bleeding Risk Associated with Warfarin Therapy
Enthalten in Clinical drug investigation Bd. 32, 29.8.2012, Nr. 2, date:2.2012: 131-137
Online Ressource
Artikel 210 Effect on the Atherogenic Marker Plasminogen Activator Inhibitor Type-1 of Addition of the ACE Inhibitor Imidapril to Angiotensin II Type 1 Receptor Antagonist Therapy in Hypertensive Patients with Abnormal Glucose Metabolism
Enthalten in Clinical drug investigation Bd. 29, 17.9.2012, Nr. 12, date:12.2009: 811-819
Online Ressource


201 - 210 von 647
<< < > >>


E-Mail-IconAdministration